In hindsight, my calling Astec Lifesciences, Vijay Kedia’s latest stock pick, a “blue chip” owing to its management pedigree was not out of place.
I theorized that with the mighty Godrej’s backing a minnow like Astec, it is only a question of time before hefty gains are on the table.
Today, Astec surged 20% in a ferocious manner, proving the correctness of my theory that when you put your faith in top-notch stocks, you will not be disappointed.
Astec Lifesciences is not alone in bringing joy to Vijay Kedia. His all-time favourite stock, Sudarshan Chemicals, has also been contributing to his financial well-being. Even newcomers to the portfolio like Apcotex Industries are showing their mettle by putting up a spirited show.
It is worth remembering that Apcotex has been certified by Daljeet Kohli as being on a “game changing” path on account of its acquisition of Omnova.
In his latest interview, Kedia rightly claimed credit for being amongst the first of the wizards to recognize the potential of chemical companies.
He revealed that he bought Sudarshan Chemicals in 2014 at Rs. 42 when nobody was interested in it. Since then, the stock has notched up impressive gains. The YoY gains itself are 71%.
Apcotex has also been a star performer with a hefty return of 85% in just 3 months.
The best part is that the story for Sudarshan Chemicals could be just beginning. Rajesh Rathi, the MD, recently stated that the Company has “great focus” on improving the return on capital and EBITDA margins and that it has “several strategic initiatives” to support the same. He promised that the good performance of the Company would continue in the future as well.
TCPL Packaging is another of Vijay Kedia’s favourite stocks that we need to keep our eye on. In addition to Kedia, TCPL has support from distinguished stock pickers such as Ramesh Damani, Dolly Khanna and Anil Kumar Goel. Sharekhan has opined that the Company is likely to be a beneficiary of the FMCG boom and the tussle for market share between Patanjali and the FMCG heavyweights!
I think he exited asteclife science….ratestar.in is showin his exit
check under – KEDIA SECURITIES PRIVATE LIMITED
#Niveza #Review ::
Looking at the fundamentals of the company, numbers are decent at current levels. The stock is trailing at PE of 19 which is reasonable. But the spike in last week can turn to some correction as well. As far as long term vision is concerned, it could be a better buy. Revenue growth is good for the company while debt is stable and in recovery phase. Signs are positive for fresh buy as well.
Stock Market Tips